The patient's sample is added to the port, where antibodies targeting the virus fusion protein can bind the antigen in the sample. Capillary action migrates the resultant complex along the strip ...

The following is a summary of “EDP-938 has a high barrier to resistance in healthy adults experimentally infected with ...

FDA has approved a vaccine to prevent lower respiratory tract disease resulting from the respiratory syncytial virus (RSV) in adults 18 to 59 years ... “In the prefusion state, the RSV fusion protein ...

Clesrovimab led to significant reductions in RSV-associated MALRI, hospitalizations, and was comparable in safety to palivizumab.

A research team at the University of Wisconsin-Madison produced high-resolution images of RSV structure, important for RSV ...

GSK has announced promising results for Arexvy, its respiratory syncytial virus (RSV) vaccine ... Arexvy combines the preF fusion protein with the AS01 adjuvant to enhance immune response in ...

Respiratory syncytial virus (RSV) is a contagious virus and a common cause of ... In the prefusion state, the RSV fusion protein (F) is a major target of neutralizing antibodies, serving as the basis ...

Clesrovimab differs from nirsevimab in that it binds to the RSV fusion protein site IV ... and safety of an investigational respiratory syncytial virus (RSV) antibody, clesrovimab, in health ...

and founding investor Medicxi – will go in part towards clinical testing of Vicebio's lead vaccine VXB-241 for respiratory syncytial virus (RSV) and human metapneumovirus (hMPV), which is in ...

The Panther and Fusion have a combined menu of about 20 assays ... tests and the company's syndromic respiratory assays for COVID-19, flu A/B, and respiratory syncytial virus. The company also said ...

This uptick in infections is happening alongside low flu jab uptake and an increase in respiratory syncytial virus (RSV ...